Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity

Regulators are reviewing what could become a multi-billion-dollar drug. Biotech companies have brought many important treatments to market, from ones that address rare diseases to ones that handle common health problems. Vertex Pharmaceuticals (VRTX -2.34%) has stood out over the past several years as a top biotech player, thanks to its work in the area of cystic fibrosis (CF). The company's portfolio of treatments is changing the lives of patients and bringing in blockbuster revenue -- in the most recent q ...